View in EDS

Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.

Saved in:
Bibliographic Details
Title: Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.
Authors: Su YJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan., Kramer AM; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California., Hamilton MP; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Agarwal N; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Srinagesh HK; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California., Baird JH; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California., Sahaf B; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California., Kuo A; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California., Ehlinger ZJ; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California., Desai MH; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California., Rietberg SP; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California., Tunuguntla R; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Patel S; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Chinnasamy H; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Gkitsas-Long N; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Klysz DD; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Brown AK; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Bharadwaj S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Dahiya S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Smith M; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Muffly L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Mackall CL; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California., Good Z; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California., Feldman SA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Miklos DB; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
Source: Cancer discovery [Cancer Discov] 2025 Apr 02; Vol. 15 (4), pp. 733-747.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39775812
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Su+YJ%22">Su YJ</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kramer+AM%22">Kramer AM</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Hamilton+MP%22">Hamilton MP</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Agarwal+N%22">Agarwal N</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Srinagesh+HK%22">Srinagesh HK</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Baird+JH%22">Baird JH</searchLink>; Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California.<br /><searchLink fieldCode="AU" term="%22Sahaf+B%22">Sahaf B</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California.<br /><searchLink fieldCode="AU" term="%22Kuo+A%22">Kuo A</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California.<br /><searchLink fieldCode="AU" term="%22Ehlinger+ZJ%22">Ehlinger ZJ</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California.<br /><searchLink fieldCode="AU" term="%22Desai+MH%22">Desai MH</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California.<br /><searchLink fieldCode="AU" term="%22Rietberg+SP%22">Rietberg SP</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Cancer Correlative Science Unit, Center for Cancer Cell Therapy, Stanford University, Palo Alto, California.<br /><searchLink fieldCode="AU" term="%22Tunuguntla+R%22">Tunuguntla R</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Patel+S%22">Patel S</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Chinnasamy+H%22">Chinnasamy H</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Gkitsas-Long+N%22">Gkitsas-Long N</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Klysz+DD%22">Klysz DD</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Brown+AK%22">Brown AK</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Bharadwaj+S%22">Bharadwaj S</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Dahiya+S%22">Dahiya S</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Smith+M%22">Smith M</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Muffly+L%22">Muffly L</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Mackall+CL%22">Mackall CL</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Division of Hematology/Oncology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Good+Z%22">Good Z</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Feldman+SA%22">Feldman SA</searchLink>; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Miklos+DB%22">Miklos DB</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Frank+MJ%22">Frank MJ</searchLink>; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, California.; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2025 Apr 02; Vol. 15 (4), pp. 733-747.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39775812
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2159-8290.CD-24-1071
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 733
    Titles:
      – TitleFull: Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Su YJ
      – PersonEntity:
          Name:
            NameFull: Kramer AM
      – PersonEntity:
          Name:
            NameFull: Hamilton MP
      – PersonEntity:
          Name:
            NameFull: Agarwal N
      – PersonEntity:
          Name:
            NameFull: Srinagesh HK
      – PersonEntity:
          Name:
            NameFull: Baird JH
      – PersonEntity:
          Name:
            NameFull: Sahaf B
      – PersonEntity:
          Name:
            NameFull: Kuo A
      – PersonEntity:
          Name:
            NameFull: Ehlinger ZJ
      – PersonEntity:
          Name:
            NameFull: Desai MH
      – PersonEntity:
          Name:
            NameFull: Rietberg SP
      – PersonEntity:
          Name:
            NameFull: Tunuguntla R
      – PersonEntity:
          Name:
            NameFull: Patel S
      – PersonEntity:
          Name:
            NameFull: Chinnasamy H
      – PersonEntity:
          Name:
            NameFull: Gkitsas-Long N
      – PersonEntity:
          Name:
            NameFull: Klysz DD
      – PersonEntity:
          Name:
            NameFull: Brown AK
      – PersonEntity:
          Name:
            NameFull: Bharadwaj S
      – PersonEntity:
          Name:
            NameFull: Dahiya S
      – PersonEntity:
          Name:
            NameFull: Smith M
      – PersonEntity:
          Name:
            NameFull: Muffly L
      – PersonEntity:
          Name:
            NameFull: Mackall CL
      – PersonEntity:
          Name:
            NameFull: Good Z
      – PersonEntity:
          Name:
            NameFull: Feldman SA
      – PersonEntity:
          Name:
            NameFull: Miklos DB
      – PersonEntity:
          Name:
            NameFull: Frank MJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 04
              Text: 2025 Apr 02
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2159-8290
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cancer discovery
              Type: main
ResultId 1